Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

HKG/0911 stock hub

HKG/0911 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

HKG/0911is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

154.2M

Hong Kong Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

HKG/0911

In the news

Latest news · HKG/0911

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11.7P50 18.9P75 41.4

Trailing P/E26

P25 10.7P50 17.9P75 38.5

ROE1.5

P25 -14.7P50 2P75 9.4

ROIC1.7

P25 -10.4P50 1.9P75 10.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All HKG/0911 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

189

Groups with data

Currency

HKD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Cayman Islands
Country code	HK
Employees	19
Employees Change	5%
Employees Change Percent	35.71
Enterprise value	HKD 93M
Exchange	Hong Kong Stock Exchange
Financial currency	HKD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	KYG7307F1046
Last refreshed	2026-05-10
Market cap	HKD 154.2M
Price	HKD 0.91
Price currency	HKD
Rev Per Employee	35,637,947.37x
Sector	Healthcare
Sic	5065
Symbol	hkg/0911
Website	https://www.qianhaihealth.com.hk

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.85%
EV Earnings	15.65x
EV/EBIT	16.41x
EV/EBITDA	12.58x
EV/Sales	0.14x
P/B ratio	0.39x
P/E ratio	25.95x
P/S ratio	0.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	0.84%
EBITDA Margin	1.09%
Gross margin	3.29%
Gross Profit	HKD 22.3M
Gross Profit Growth	2,296.23%
Gross Profit Growth3 Y	-44.05%
Net Income	HKD 5.9M
Net Income Growth	353.17%
Net Income Growth Quarters	1%
Net Income Growth Years	3%
Net Income Growth3 Y	-57.05%
Pretax Margin	0.88%
Profit Margin	0.88%
Profit Per Employee	HKD 312,684
Profitable Years	2
ROA	0.87
Roa5y	-4.21
ROCE	1.45
ROE	1.53
Roe5y	-10.66
ROIC	1.72
Roic5y	-7.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-27.94%
Cagr1y	344.36%
Cagr3y	4.83%
Cagr5y	-5.85%
Div CAGR10	0%
EPS Growth	353.2
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	-57.05
Revenue Growth	30.29x
Revenue Growth Q	58.07x
Revenue Growth Quarters	1x
Revenue Growth Years	1x
Revenue Growth3 Y	-9.98x
Revenue Growth5 Y	-9.25x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 1.66
Assets	HKD 408.4M
Cash	HKD 61.6M
Current Assets	HKD 388.7M
Current Liabilities	HKD 17.2M
Debt	HKD 424,000
Debt EBITDA	HKD 0.06
Debt Equity	HKD 0
Equity	HKD 391.2M
Interest Coverage	149.2
Liabilities	HKD 17.2M
Long Term Assets	HKD 19.6M
Long Term Liabilities	HKD 0
Net Cash	HKD 61.2M
Net Cash By Market Cap	HKD 39.7
Net Cash Growth	172.35%
Net Debt EBITDA	HKD -8.28
Net Debt Equity	HKD -0.16
Tangible Book Value	HKD 391.2M
Tangible Book Value Per Share	HKD 2.31
WACC	12.78

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	22.62
Inventory Turnover	3.61
Net Working Capital	HKD 310.3M
Quick ratio	16.54
Working Capital	HKD 371.6M
Working Capital Turnover	HKD 1.84

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend per share	HKD 0
Last Dividend	HKD 0.1

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.22%
1Y total return	343.9%
200-day SMA	0.31
3Y total return	15.19%
50-day SMA	0.4
50-day SMA vs 200-day SMA	50over200
5Y total return	-26.02%
All Time High	408
All Time High Change	-99.78%
All Time High Date	2015-06-29
All Time Low	0.14
All Time Low Change	559.42%
All Time Low Date	2024-09-03
ATR	0.16
Beta	1.55
Beta1y	-0.99
Beta2y	-0.58
Ch YTD	230.9
High	0.95
High52	1.4
High52 Date	2026-04-30
High52ch	-35%
Low	0.84
Low52	0.17
Low52 Date	2025-05-27
Low52ch	429.07%
Ma50ch	126.59%
Price vs 200-day SMA	195.26%
RSI	61.49
RSI Monthly	69.99
RSI Weekly	90.8
Sharpe ratio	1.37x
Sortino ratio	4.57
Tr YTD	230.9
Tr1m	243.4%
Tr1w	-12.5%
Tr3m	250%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	HKD 5.7M
Operating Income Growth3 Y	-60.97
Operating margin	0.84

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	80,196,423%
Shares Institutions	0.56%
Shares Out	169,445,000
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	3,062,079.4x
Bv Per Share	2.31
Ch10y	-96.27
Ch1m	243.4
Ch1w	-12.5
Ch1y	343.9
Ch3m	250
Ch3y	15.19
Ch5y	-26.02
Ch6m	193.5
Change	3.41%
Change From Open	8.33
Close	0.88
Days Gap	-4.55
Depreciation Amortization	1,721,000
Dollar Volume	338,065
Earnings Date	2026-05-20
EBIT	HKD 5.7M
EBITDA	HKD 7.4M
EPS	HKD 0.04
F Score	4
Fiscal Year End	December
Founded	1,989
Graham Number	1.34955
Graham Upside	48.3
Income Tax	HKD 2,000
Is Primary Listing	1
Last Earnings Date	2026-03-18
Last Report Date	2025-12-31
Last Split Date	2024-05-20
Last Split Type	Reverse
Lynch Fair Value	HKD 0.18
Lynch Upside	-80.74
Ma150	0.32
Ma150ch	182.61%
Ma20	0.58
Ma20ch	56.49%
Next Earnings Date	2026-05-20
Open	0.84
Position In Range	63.64
Ppne	19,649,000
Price Date	2026-05-08
Price EBITDA	HKD 20.87
Ptbv Ratio	0.39
Relative Volume	0.12x
Revenue	677,121,000x
Tax By Revenue	0x
Tax Rate	0.03%
Tr6m	193.55%
Volume	371,500
Z Score	5.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does HKG/0911 pay a dividend?

Capital-return profile for this ticker.

Performance

HKG/0911 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns HKG/0911?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.6%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

HKG/0911 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

61.5

Neutral momentum band

Price vs 200-day MA

+195.3%

50/200-day relationship not available

Beta (5Y)

1.55

More volatile than the market

Sharpe ratio

1.37

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About HKG/0911

Hub-level FAQ points readers to the deeper analysis pages.

What is the current hkg/0911 stock rating?

hkg/0911 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full hkg/0911 analysis?

The full report lives at /stocks/hkg/0911/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for hkg/0911?

The latest report frames hkg/0911 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the hkg/0911 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.